scispace - formally typeset
Search or ask a question
Institution

University of Ottawa

EducationOttawa, Ontario, Canada
About: University of Ottawa is a education organization based out in Ottawa, Ontario, Canada. It is known for research contribution in the topics: Population & Health care. The organization has 36763 authors who have published 87034 publications receiving 2913651 citations. The organization is also known as: uOttawa & U of O.


Papers
More filters
Journal ArticleDOI
TL;DR: It is found the majority of coinfected patients were not included in clinical trials of direct-acting antivirals, raising concerns about the generalizability of these trial results.
Abstract: (See the Editorial Commentaries by Martinello and Dore on pages 927–8.) Worldwide, approximately 5 million people are coinfected with human immunodeficiency virus (HIV) and hepatitis C (HCV) [1]. Coinfected people are heterogeneous, have complex medical needs, and are often socially disenfranchised. Injection drug use is responsible for the majority of both incident and prevalent cases in most developed countries. Despite effective HIV suppression and immune restoration, liver disease remains the leading cause of death in HIV–HCV coinfected individuals [2–4]. To reduce the clinical and healthcare burden of advanced liver disease, coinfected individuals need to be treated and cured of HCV [5–7]. Unfortunately, fewer than 10% of coinfected individuals have ever been treated [8, 9]. The development of direct-acting antivirals (DAAs) for HCV has been rightfully described as revolutionary. Based on compelling clinical trial results, multiple DAAs, including simeprevir; sofosbuvir; ledipasvir; ombitasvir; paritaprevir/ritonavir/dasabuvir (3D); and daclatasvir have been approved by licensing authorities globally [10–16]. Clinical trial results show that DAAs are well tolerated, more conveniently dosed, and highly efficacious compared with earlier interferon-based HCV therapies. Among interferon-free DAA trials, with as little as 12 to 24 weeks of treatment, sustained virologic response (SVR) rates ranged from 91% to 97% across genotypes and fibrosis stages in coinfected individuals, representing a remarkable advance compared with previous therapies [17–19]. Trials evaluating these new agents have so far included relatively small numbers of participants (subgroups ranging from 6 to 160) and have applied very strict eligibility criteria, likely excluding a substantial segment of the coinfected population. Substance abuse, comorbid medical and psychiatric conditions, advanced liver disease, and drug–drug interactions with antiretrovirals are common and among some of the primary factors that may influence access to treatment and outcomes in the real world [20, 21]. This raises the question: If a large proportion of coinfected patients are excluded from participating in clinical trials, how generalizable are DAA trials for people living with HIV–HCV coinfection?

69 citations

Journal ArticleDOI
TL;DR: It is shown that Artemis is constitutively phosphorylated in cultured cells and undergoes additional phosphorylation events after irradiation, an effector of DNA repair that can beosphorylated by ATM, and possibly by DNA‐PKcs and ATR depending upon the type of DNA damage.
Abstract: Artemis is a DNA repair factor required for V(D)J recombination, repair of DNA damage induced by ionizing radiation (IR) or radiomimetic drugs, and the maintenance of genome integrity. During V(D)J recombination, Artemis participates in the resolution of hairpin-sealed coding ends, a step crucial to the constitution of the gene encoding for the antigen receptor of lymphocytes. The precise role of Artemis in the repair of IR-induced DNA damage remains to be elucidated. Here we show that Artemis is constitutively phosphorylated in cultured cells and undergoes additional phosphorylation events after irradiation. The IR-induced phosphorylation is mainly, although not solely, dependent on Ataxia-telangiectasia-mutated kinase (ATM). The physiological role of these phosphorylation events remains unknown, as in vitro-generated Artemis mutants, which present impaired IR-induced phosphorylation, still display an activity sufficient to complement the V(D)J recombination defect and the increased radiosensibility of Artemis-deficient cells. Thus, Artemis is an effector of DNA repair that can be phosphorylated by ATM, and possibly by DNA-PKcs and ATR depending upon the type of DNA damage.

69 citations

Journal ArticleDOI
TL;DR: In this article, a Grignard reaction performed in a micro-reactor is presented, which is of type A (highly exothermic and very rapid) and has a low yield which is attributed to a hot spot formed in the mixing zone of the reactor.
Abstract: A Grignard reaction performed in a microreactor is presented. The reaction is of type A (highly exothermic and very rapid) and has a low yield which is attributed to a hot spot formed in the mixing zone of the reactor. The reaction yield could be significantly increased by applying the multi-injection principle, leading to better thermal control in the microreactor. Nevertheless, the microreactor plays a major role in reducing the magnitude of the hot spot. Knowing this, it was possible to design and construct an industrial microreactor with significant advantages such as modularity, high flow rate operation, and low investment expenditure (pumps and flow controller minimization).

69 citations

Journal ArticleDOI
TL;DR: An unusual dinuclear Yb(2) complex isolated using a mixed ligand strategy leads to field-induced SMM behaviour with low magnetic axiality and a large tunnelling gap.
Abstract: An unusual dinuclear Yb2 complex isolated using a mixed ligand strategy leads to field-induced SMM behaviour. Low magnetic axiality and a large tunnelling gap lead to significant quantum tunnelling of the magnetisation, which was reduced under an applied static optimum field of 1600 Oe.

69 citations

Posted Content
TL;DR: In this paper, the authors consider the symmetry-breaking steady state bifurcation of a spatially-uniform equilibrium solution of E(2)-equivariant PDEs, and restrict the space of solutions to those that are doubly-periodic with respect to a square or hexagonal lattice.
Abstract: We consider the symmetry-breaking steady state bifurcation of a spatially-uniform equilibrium solution of E(2)-equivariant PDEs. We restrict the space of solutions to those that are doubly-periodic with respect to a square or hexagonal lattice, and consider the bifurcation problem restricted to a finite-dimensional center manifold. For the square lattice we assume that the kernel of the linear operator, at the bifurcation point, consists of 4 complex Fourier modes, with wave vectors K_1=(a,b), K_2=(-b,a), K_3=(b,a), and K_4=(-a,b), where a>b>0 are integers. For the hexagonal lattice, we assume that the kernel of the linear operator consists of 6 complex Fourier modes, also parameterized by an integer pair (a,b). We derive normal forms for the bifurcation problems, which we use to compute the linear, orbital stability of those solution branches guaranteed to exist by the equivariant branching lemma. These solutions consist of rolls, squares, hexagons, a countable set of rhombs, and a countable set of planforms that are superpositions of all of the Fourier modes in the kernel. Since rolls and squares (hexagons) are common to all of the bifurcation problems posed on square (hexagonal) lattices, this framework can be used to determine their stability relative to a countable set of perturbations by varying a and b. For the hexagonal lattice, we analyze the degenerate bifurcation problem obtained by setting the coefficient of the quadratic term to zero. The unfolding of the degenerate bifurcation problem reveals a new class of secondary bifurcations on the hexagons and rhombs solution branches.

69 citations


Authors

Showing all 37148 results

NameH-indexPapersCitations
Douglas G. Altman2531001680344
Cyrus Cooper2041869206782
Rakesh K. Jain2001467177727
Robert M. Califf1961561167961
Eric J. Topol1931373151025
Jasvinder A. Singh1762382223370
Deborah J. Cook173907148928
Marc A. Pfeffer166765133043
Richard M. Ryan164405244550
Christopher J. O'Donnell159869126278
Jean M. J. Fréchet15472690295
Stephen J. O'Brien153106293025
George A. Wells149941114256
Nilesh J. Samani149779113545
Seeram Ramakrishna147155299284
Network Information
Related Institutions (5)
University of British Columbia
209.6K papers, 9.2M citations

93% related

University of Toronto
294.9K papers, 13.5M citations

93% related

McGill University
162.5K papers, 6.9M citations

93% related

University of California, Irvine
113.6K papers, 5.5M citations

90% related

University of Southern California
169.9K papers, 7.8M citations

89% related

Performance
Metrics
No. of papers from the Institution in previous years
YearPapers
2023187
2022665
20215,989
20205,712
20195,144
20184,736